Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211) - Kunz, PL; Graham, NT; Catalano, PJ (J Clin Oncol, 2023)
et al.